SCHEMBL7302465

SCHEMBL7302465

COC(=O)C(NC(=O)N(C)Cc1nc2ccccc2[nH]1)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HSD17B10 Q99714 2/20 0.50
MAPT P10636 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 2/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
PIN1 Q13526 3/20 0.44
BCHE P06276 1/20 0.44
HTT P42858 2/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
PKM P14618 1/20 0.43
CACNA1G O43497 1/20 0.43
KCNH2 Q12809 1/20 0.43
CACNA1C Q13936 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302472 1.00 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HSD17B10MAPTTDP1
SCHEMBL7310781 0.89 TDP1 (0.55) ALDH1A1SMN1; SMN2HSD17B10MAPTTDP1
SCHEMBL7310787 0.89 TDP1 (0.55) ALDH1A1SMN1; SMN2HSD17B10MAPTTDP1
SCHEMBL7307803 0.83 PKM (0.49) ALDH1A1SMN1; SMN2MAPTTDP1KDM4E
SCHEMBL7307810 0.83 PKM (0.49) ALDH1A1SMN1; SMN2MAPTTDP1KDM4E
SCHEMBL7333674 0.79 CA2 (0.64) ALDH1A1MAPTTDP1KDM4EPIN1
SCHEMBL7333388 0.79 CA2 (0.64) ALDH1A1MAPTTDP1KDM4EPIN1
SCHEMBL7333130 0.79 CA2 (0.64) ALDH1A1MAPTTDP1KDM4EPIN1
SCHEMBL11353994 0.75 TDP1 (0.68) ALDH1A1SMN1; SMN2HSD17B10MAPTTDP1
SCHEMBL14276925 0.75 TDP1 (0.64) ALDH1A1SMN1; SMN2HSD17B10MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed